+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Serum-Free Media Market - Global Forecast 2026-2030- Product Image
Serum-Free Media Market - Global Forecast 2026-2030- Product Image
New

Serum-Free Media Market - Global Forecast 2026-2030

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6084041
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The serum-free media market is fast becoming a cornerstone for companies in biopharmaceutical and advanced therapy sectors, supporting innovation, regulatory compliance, and resilience amid shifting global manufacturing landscapes. For senior decision-makers, navigating this evolving market requires a strategic view of supply chain robustness, regulatory trends, and tailored solutions to meet diverse operational priorities.

Market Snapshot: Serum-Free Media Market Size and Growth

The Serum-Free Media Market is projected to rise from USD 2.51 billion in 2024 to USD 2.76 billion in 2025, with an expected compound annual growth rate (CAGR) of 10.07%, positioning it to reach USD 4.47 billion by 2030. This robust market trajectory reflects mounting industry efforts to satisfy increasingly complex regulatory, operational, and technical demands across biologics and advanced therapeutics development.

Scope & Segmentation

  • Product Types: Custom media solutions provide project-specific nutrient optimization, while defined media address broad compatibility and standardization needs.
  • Media Formats: Chemically Defined Media (CDM) and common serum-free media offer reliable performance, while Non-Animal Origin (NAO), Protein-Free, and Xeno-Free variations help align with regulatory requirements and precise process controls.
  • Cell Hosts: Mammalian cell systems—such as CHO-DG44, CHO-DXB11, CHO-K1, HEK293, NS0, and Vero—alongside non-mammalian models like insect and yeast, call for distinct nutrient and growth factor profiles.
  • Formulations: Liquid and powdered forms affect shelf life, transportation efficiency, and ease of preparation in production settings.
  • Applications: Academic research drives method advancement, biopharmaceutical production supports commercial-scale mAbs and vaccines, cell and gene therapies require specialized media for emerging treatments like CAR-T, and tissue engineering enables research and regenerative medicine.
  • End Users: Biotechnology companies, contract research organizations, and pharmaceutical companies exhibit varied priorities related to documentation, batch volumes, and technical support.
  • Regions: Americas benefit from supplier clustering, while Europe, Middle East & Africa, and Asia-Pacific differ based on local innovation, regulation, and supply-chain strategies.

Key Takeaways: Strategic Insights for the Serum-Free Media Market

  • Serum-free media now hold a central role in biologics and advanced therapy manufacturing, supporting collaboration among R&D, manufacturing, and quality teams.
  • Regulatory momentum favors animal-origin avoidance, supporting rapid uptake of chemically defined, xeno-free, and protein-free options that offer traceability and batch-to-batch consistency.
  • Technical evolution in cell engineering expands the need for custom serum-free variants, addressing novel and non-standard cell lines and supporting development flexibility.
  • Procurement and quality stakeholders increasingly address regional supply risks and tiered vendor dependencies by fostering long-term supplier partnerships and enabling adaptive sourcing strategies.
  • Regional sourcing strategies adjust to local regulatory harmonization and the need for domestic innovation, as suppliers balance cluster efficiencies with compliance and delivery assurance.
  • Supplier relevance hinges on advanced formulation capabilities, co-development programs, and clear documentation—driving selection criteria for long-term relationships and operational trust.

Tariff Impact: Navigating Cross-Border Procurement Complexity

In response to recent US tariff developments, procurement leaders are tasked with mitigating exposure to cost fluctuations and supply interruptions. Actionable steps include managing buffer inventories, qualifying new domestic and alternative suppliers, and monitoring raw ingredient origins. These efforts help assure continued biomanufacturing operations and support adherence to demanding regulatory and quality documentation standards in a rapidly evolving trade environment.

Methodology & Data Sources

This market analysis is underpinned by a mixed-methods approach comprising structured stakeholder interviews, technical literature reviews, laboratory validation datasets, and rigorous supply chain mapping. Engaging procurement, quality assurance, and manufacturing perspectives ensures findings align with real-world operational needs and inform practical decisions for senior leadership.

Why This Report Matters

  • Enables organizations to proactively manage supplier risks, align with evolving regulations, and develop tailored media solutions that maintain continuity and compliance.
  • Guides data-driven strategy development, equipping decision-makers to connect segment shifts, technological innovation, and regional policy changes for actionable market positioning.
  • Supports senior leaders in refining procurement processes, expediting program goals, and sustaining high-quality standards in biologics and advanced therapeutic manufacturing pipelines.

Conclusion

Serum-free media form the backbone of reliable and scalable developments in biologics and cell-based therapies. Strategic segmentation, resilient sourcing, and robust supplier collaboration will define competitive advantage across this pivotal industry landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2024
3.5. FPNV Positioning Matrix, 2024
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Serum-Free Media Market, by Product Type
8.1. Custom Media
8.2. Defined Media
9. Serum-Free Media Market, by Serum-Free Media Type
9.1. Chemically Defined Media (CDM)
9.2. Common Serum-Free Media (SFM)
9.3. Non-Animal Origin (NAO) Media
9.4. Protein-Free Media (PFM)
9.5. Xeno-Free Media
10. Serum-Free Media Market, by Cell Type
10.1. Mammalian Cells
10.1.1. CHO Cells
10.1.1.1. CHO-DG44
10.1.1.2. CHO-DXB11
10.1.1.3. CHO-K1
10.1.2. HEK293
10.1.3. NS0 Cells
10.1.4. Vero Cells
10.2. Non-Mammalian Cells
10.2.1. Insect Cells
10.2.2. Yeast Cells
11. Serum-Free Media Market, by Formulation
11.1. Liquid Form
11.2. Powdered Form
12. Serum-Free Media Market, by Application
12.1. Academic Research
12.1.1. Gene Editing
12.1.2. Stem Cell Research
12.2. Biopharmaceutical Production
12.2.1. Monoclonal Antibodies
12.2.2. Recombinant Proteins
12.2.3. Vaccines
12.3. Cell & Gene Therapy
12.3.1. CAR-T Therapy
12.3.2. Stem Cell Therapy
12.4. Tissue Engineering & Regenerative Medicine
13. Serum-Free Media Market, by End User
13.1. Biotechnology Companies
13.2. Contract Research Organizations
13.3. Pharmaceutical Companies
14. Serum-Free Media Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Serum-Free Media Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Serum-Free Media Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Serum-Free Media Market
18. China Serum-Free Media Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2024
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2024
19.3. Product Portfolio Analysis, 2024
19.4. Benchmarking Analysis, 2024
19.5. Ajinomoto Co., Inc.
19.6. Becton, Dickinson and Company
19.7. Bio-Techne Corporation
19.8. Corning Incorporated
19.9. Danahar Corporation
19.10. FUJIFILM Holdings Corporation
19.11. Lonza Group AG
19.12. Merck KGaA
19.13. MP Biomedicals, LLC
19.14. Sartorius AG
19.15. STEMCELL Technologies Canada Inc.
19.16. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 2. GLOBAL SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 3. GLOBAL SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 14. CHINA SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 2. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 3. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CUSTOM MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CUSTOM MEDIA, BY GROUP, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CUSTOM MEDIA, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY DEFINED MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY DEFINED MEDIA, BY GROUP, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY DEFINED MEDIA, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHEMICALLY DEFINED MEDIA (CDM), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHEMICALLY DEFINED MEDIA (CDM), BY GROUP, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHEMICALLY DEFINED MEDIA (CDM), BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COMMON SERUM-FREE MEDIA (SFM), BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COMMON SERUM-FREE MEDIA (SFM), BY GROUP, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COMMON SERUM-FREE MEDIA (SFM), BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-ANIMAL ORIGIN (NAO) MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-ANIMAL ORIGIN (NAO) MEDIA, BY GROUP, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-ANIMAL ORIGIN (NAO) MEDIA, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PROTEIN-FREE MEDIA (PFM), BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PROTEIN-FREE MEDIA (PFM), BY GROUP, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PROTEIN-FREE MEDIA (PFM), BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY XENO-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY XENO-FREE MEDIA, BY GROUP, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY XENO-FREE MEDIA, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO-DG44, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO-DG44, BY GROUP, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO-DG44, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO-DXB11, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO-DXB11, BY GROUP, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO-DXB11, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO-K1, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO-K1, BY GROUP, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO-K1, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY HEK293, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY HEK293, BY GROUP, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY HEK293, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NS0 CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NS0 CELLS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NS0 CELLS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VERO CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VERO CELLS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VERO CELLS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY INSECT CELLS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY INSECT CELLS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY YEAST CELLS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY YEAST CELLS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY LIQUID FORM, BY GROUP, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY LIQUID FORM, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY POWDERED FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY POWDERED FORM, BY GROUP, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY POWDERED FORM, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VACCINES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CAR-T THERAPY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CAR-T THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL THERAPY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 111. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 112. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 114. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 115. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 133. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 134. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 135. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 136. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 137. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 140. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 141. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 142. NORTH AMERICA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 144. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 146. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 147. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 148. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 149. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 150. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 151. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 153. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 154. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 155. LATIN AMERICA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 170. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 173. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 174. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 175. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 177. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 179. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 180. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 181. EUROPE SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 183. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 185. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 186. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 187. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 188. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 189. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 190. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 192. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 193. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 194. MIDDLE EAST SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 196. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 198. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 199. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 200. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 201. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 202. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 203. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 205. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 206. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 207. AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 222. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 223. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 225. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 226. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 227. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 228. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 229. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 230. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 232. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 233. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 234. ASEAN SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. GCC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 236. GCC SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. GCC SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 238. GCC SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 239. GCC SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 240. GCC SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 241. GCC SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 242. GCC SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 243. GCC SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. GCC SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 245. GCC SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 246. GCC SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 247. GCC SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 249. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 251. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 252. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 253. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 254. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 255. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 256. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 258. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 259. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 260. EUROPEAN UNION SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. BRICS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 262. BRICS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. BRICS SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 264. BRICS SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 265. BRICS SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 266. BRICS SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 267. BRICS SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 268. BRICS SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 269. BRICS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. BRICS SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 271. BRICS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 272. BRICS SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 273. BRICS SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. G7 SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. G7 SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. G7 SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 277. G7 SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 278. G7 SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 279. G7 SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 280. G7 SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 281. G7 SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 282. G7 SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. G7 SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 284. G7 SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 285. G7 SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 286. G7 SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. NATO SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 288. NATO SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. NATO SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 290. NATO SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 291. NATO SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 292. NATO SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 293. NATO SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 294. NATO SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 295. NATO SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. NATO SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 297. NATO SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 298. NATO SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 299. NATO SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 301. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 302. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 304. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 305. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 306. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 307. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 308. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 309. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 311. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 312. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 313. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. CHINA SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 315. CHINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. CHINA SERUM-FREE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA TYPE, 2018-2030 (USD MILLION)
TABLE 317. CHINA SERUM-FREE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 318. CHINA SERUM-FREE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 319. CHINA SERUM-FREE MEDIA MARKET SIZE, BY CHO CELLS, 2018-2030 (USD MILLION)
TABLE 320. CHINA SERUM-FREE MEDIA MARKET SIZE, BY NON-MAMMALIAN CELLS, 2018-2030 (USD MILLION)
TABLE 321. CHINA SERUM-FREE MEDIA MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 322. CHINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. CHINA SERUM-FREE MEDIA MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 324. CHINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 325. CHINA SERUM-FREE MEDIA MARKET SIZE, BY CELL & GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 326. CHINA SERUM-FREE MEDIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)

Companies Mentioned

The key companies profiled in this Serum-Free Media market report include:
  • Ajinomoto Co., Inc.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • BioIVT LLC
  • Biowest
  • Celprogen Corporation
  • Corning Incorporated
  • Danahar Corporation
  • ExCell Bio Group
  • FUJIFILM Holdings Corporation
  • Gmep Incorporated
  • Hangzhou Jimi Biotechnology Co., Ltd
  • HiMedia Laboratories Private Limited
  • Kyokuto Pharmaceutical Industrial Co., Ltd
  • Leinco Technologies, Inc.
  • Lonza Group AG
  • Merck KGaA
  • MP Biomedicals, LLC
  • Myoridge Co. Ltd.
  • Nucleus Biologics
  • PAN-Biotech GmbH
  • PromoCell GmbH
  • R&D Systems, Inc.
  • REPROCELL Inc.
  • Sartorius AG
  • Shanghai BioEngine Sci-Tech Co., Ltd
  • Sino Biological, Inc.
  • STEMCELL Technologies Canada Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • Xcell Therapeutics Inc.
  • Yocon Biology Technology Company

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.76 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.47 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned33

Related Topics

Related Reports

Reduced Serum Cell Culture Media Market - Global Forecast 2026-2032 - Product Image

Reduced Serum Cell Culture Media Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Serum Free Media Market Report 2025 - Product Image

Serum Free Media Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pure Suspension Cell Culture Medium Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Pure Suspension Cell Culture Medium Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Serum-Free Media Market - Global Strategic Business Report - Product Image

Serum-Free Media Market - Global Strategic Business Report

  • Report
  • 476 Pages
  • Global
From
GMP Grade Cell Culture Media Market - Global Forecast 2026-2032 - Product Image

GMP Grade Cell Culture Media Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.